Carbohydrates Test and In Vitro Inhibitory Activities of AlphaGlucosidase and Alpha-Amylase of Stem Bark Extracts of Musanga Cecropioides

Journal Title: Open Access Journal of Pharmaceutical Research - Year 2020, Vol 4, Issue 2

Abstract

Elevated postprandial hyperglycemia is one of the risk factors linked to diabetes. Decreasing postprandial hyperglycemia is possible by inhibiting certain carbohydrate hydrolyzing enzymes like α-amylase and α-glucosidase. Our study aimed to assess Oral Maltose and Starch tolerance Test, in the presence of the aqueous extract of Musanga cecropioides in male rats and to measure the α-glucosidase and α-amylase inhibiting activities in vitro in the presence of the fractions obtained from M. cecropioides. The results obtained show that the aqueous extract at the doses used did not significantly reduce the Area Under the Curve in comparison with the groups of animals receiving only water and maltose or those receiving water with starch. In contrast, glibenclamide at a dose of 10 mg/kg induced a significant drop in both the Area Under the Curve induced by maltose and that induced by starch respectively. As regards the inhibition of α-glucosidase activity, the fractions A, B, C, and D showed respective median inhibitory concentrations of 14.84, 83.10, 69.86, and 0.70 µg/mL compared to acarbose (positive control) and fraction D had the best half-maximal inhibitory concentration (IC50) of 0.70 µg/mL. In terms of inhibition of α-amylase activity, the median inhibitory concentrations (IC50) for fraction A, Fraction B, Fraction C, and fraction D were 63.51, 221.5, 691.1 and 604.4 µg/mL respectively. This study shows that fraction A has α-glucosidase and α-amylase inhibiting activities, while fraction D has very pronounced α-glucosidase activity. It would be necessary to further split fractions A and D, to determine the compounds responsible for their activity of inhibiting α-glucosidase and α-amylase.

Authors and Affiliations

Tchamgoué DA, Kopa KT, Nyunaï N*, Diboué Betote PH, Nguimmo MA and Medou MF

Keywords

Related Articles

Carbohydrates Test and In Vitro Inhibitory Activities of AlphaGlucosidase and Alpha-Amylase of Stem Bark Extracts of Musanga Cecropioides

Elevated postprandial hyperglycemia is one of the risk factors linked to diabetes. Decreasing postprandial hyperglycemia is possible by inhibiting certain carbohydrate hydrolyzing enzymes like α-amylase and α-glucosidase...

Medical Imaging Scans: A Short Letter

The medical imaging scans of various organs of the body have become an indispensable tool for medical fraternity which helps them in planning various surgical procedures. These scans depict the anatomical, structural and...

Pandemic of Coronavirus 19: A Comprehensive Literature Review, Therapeutic Options and Possible Lessons from SARS-COV Therapy

There are new public health emergencies debilitating world with the spread of the coronavirus disease 2019. This presents an inventive challenge to identify useful drugs for therapy. A new coronavirus was found in China...

Detonation Nanodiamonds: Opportunity for Pharmaceutical and Medical Application

Detonation nanodiamonds have 4-5 nm size primary particles, stable inert core, high surface area and tunable surface structures. They are very attractive from pharmaceutical point of view as a drug delivery vehicle. Nitr...

COVID 19 in Children

Corona is a common viral disease that can be transmitted between humans and different types of animals, meaning it can be transmitted between different races and types of living organisms. It is characterized as having...

Download PDF file
  • EP ID EP746355
  • DOI 10.23880/oajpr-16000202
  • Views 44
  • Downloads 0

How To Cite

Tchamgoué DA, Kopa KT, Nyunaï N*, Diboué Betote PH, Nguimmo MA and Medou MF (2020). Carbohydrates Test and In Vitro Inhibitory Activities of AlphaGlucosidase and Alpha-Amylase of Stem Bark Extracts of Musanga Cecropioides. Open Access Journal of Pharmaceutical Research, 4(2), -. https://europub.co.uk/articles/-A-746355